Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo- Controlled Clinical Trial
The above paper was done in the USA using umbilical cord stem cells to show clinically the benefits of stem cells for Aging Fraility in 2017.
